Top BPC-157 Studies: Research Category Comparison
Gastric Protection (1991–2010) Nitric oxide modulation, mucus stabilisation, microvascular blood flow NSAID-induced ulcers, ethanol damage, cysteamine lesions High. Consistent dose-response, multiple research groups, quantifiable histological endpoints Human t
This comparison does not assign a generated winner or score.
- Gastric Protection (1991–2010)
- Nitric oxide modulation, mucus stabilisation, microvascular blood flow
- NSAID-induced ulcers, ethanol damage, cysteamine lesions
- High. Consistent dose-response, multiple research groups, quantifiable histological endpoints
- Human trials limited to case reports; optimal dosing and administration route for clinical use undefined
- Most robust evidence base; mechanism well-characterised across multiple injury models with reproducible results
- Musculoskeletal Repair (2009–2018)
- VEGF upregulation, angiogenesis at injury sites, collagen organisation
- Achilles tendon transection, MCL tears, crush injuries to skeletal muscle
- Moderate. Surgical models with controlled injuries; biomechanical testing standardised
- Acute injury models only; chronic tendinopathy and overuse conditions underrepresented; human dosing extrapolation unclear
- Convincing acute injury data; effect size clinically meaningful but overstated in non-peer-reviewed sources
- Neuroprotection (2016–2023)
- Dopamine pathway modulation, oxidative stress reduction, BBB integrity
- Traumatic brain injury, amphetamine/haloperidol-induced disruption
- Moderate. Emerging field with fewer replication studies; mechanisms incompletely characterised
- Blood-brain barrier crossing pathway unclear; delayed-treatment protocols ineffective; no human neurological case data
- Promising preclinical signals; insufficient data to support cognitive or psychiatric applications in humans